What GHK-Cu Compound Is

An independent editorial project

GHK-Cu Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on GHK-Cu, the copper tripeptide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site exists because the published record on GHK-Cu is unusually composable — one small copper-binding peptide whose reported activity partitions cleanly into a handful of research domains: skin and collagen, hair-follicle, wound-healing and angiogenesis, gene-expression, antioxidant chemistry, and safety. We read that record the way a diagram reads a whole: each domain is a segment, the headline proportions live in the center, and every slice ties back to a study. The aim is that a reader can see where the copper signal lands and how much, while the prose holds the honest detail underneath.

What "Compound" means here

The word "Compound" in this site's name is chemical-substance framing, not a claim about services. GHK-Cu is, literally, a compound — a tripeptide chelated to a copper(II) ion — and the name signals the neutral, composition-of-a-whole register this digest takes. It is not a clinic, a pharmacy, a telehealth service, or a vendor, and it does not offer treatment, consultation, or prescriptions of any kind. Any modifier elsewhere in the portfolio that sounds clinical is editorial framing about a position relative to the literature, never a description of a healthcare service offered here.

How we handle the evidence

Every quantitative claim on this site — every concentration, percentage, hair count, gene-modulation figure, and molecular constant — maps to a numbered citation drawn from the peer-reviewed literature, listed on the references page with DOIs and PubMed identifiers. We distinguish carefully between the free GHK peptide and the copper-bound GHK-Cu complex, because most documented activity is copper-dependent and the two are routinely conflated elsewhere ^[7]. We are equally explicit about the gaps: much of the gene-expression literature traces to a single investigator and his colleagues and awaits independent protein-level validation, and there is no validated human pharmacokinetic data for systemic GHK-Cu ^[2][3]. Where a study tested an analog rather than GHK-Cu, we say so. The goal is a record a reader can trust precisely because its limits are stated as clearly as its findings.